Results 51 to 60 of about 1,586 (183)
Abstract Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke‐like episodes (MELAS) is a rare multisystem mitochondrial disorder primarily caused by mutations in mitochondrial DNA. While it typically presents with stroke‐like episodes, seizures, and lactic acidosis, recent evidence highlights a broader clinical spectrum, including ...
Faezeh Khorshidian +3 more
wiley +1 more source
CARRIER ERYTHROCYTE ENTRAPPED THYMIDINE PHOSPHORYLASE THERAPY FOR MNGIE [PDF]
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive condition caused by mutations in the nuclear gene ECGF1 coding for thymidine phosphorylase (TP).1,2 Clinical features include gastrointestinal dysmotility, peripheral sensorimotor polyneuropathy, progressive external ophthalmoplegia, and hepatopathy.
Moran, N. F. +3 more
openaire +4 more sources
Mitochondrial DNA Depletion Syndrome 1 (MTDPS1)—A Novel Cause of Premature Ovarian Insufficiency
We describe a woman with MNGIE due to a novel homozygous TYMP nonsense variant and propose MNGIE as the cause of her premature ovarian insufficiency—a rarely reported association—highlighting the need to consider mitochondrial disease in unexplained POI, especially in atypical, consanguineous presentations. ABSTRACT Mitochondrial DNA depletion syndrome
Michael Matheou +3 more
wiley +1 more source
International Forum on Visceral Myopathy 2024: Advances in the Knowledge of the Disease
As an orphan disease, where treatment is not curative and diagnosis is often slow, VSCM represents a serious health and social problem requiring research efforts in several directions. ABSTRACT Background Visceral myopathy (VSCM) is an ultra‐rare life‐threatening condition characterized by severe impairment of gastrointestinal (GI), genitourinary, and ...
Pascal de Santa Barbara +42 more
wiley +1 more source
The purpose of this protocol is to report the methodology for the development of a Core Outcome Set (COS) for the mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). A COS represents the minimum that should be measured in a clinical trial for a particular condition. The aim of the COLT-MNGIE project is to develop a COS to be used in research
Rinaldi, Rita +12 more
openaire +1 more source
POLG1-related mitochondrial disorder with MNGIE- and leigh-like features
Josef Finsterer
openalex +4 more sources
UEG Week 2023 Moderated Posters
United European Gastroenterology Journal, Volume 11, Issue S8, Page 201-534, October 2023.
wiley +1 more source
ABSTRACT Liver transplantation (LTx) has become, over the years, an increasingly used therapeutic option in patients with inherited metabolic diseases (IMD). Initially performed for Tyrosinemia Type I and ornithine transcarbamylase deficiency, it now accounts as the second indication for pediatric transplants worldwide. The use of LTx has been extended
Andrea Pietrobattista +3 more
wiley +1 more source
UEG Week 2023 Poster Presentations
United European Gastroenterology Journal, Volume 11, Issue S8, Page 535-1498, October 2023.
wiley +1 more source
Mitochondrial neuro gastrointestinal encephalopathy (MNGIE) is a rare autosomal recessive genetic condition caused mainly by thymidine phosphorylates (TP) deficiency and TYMP mutations.
S. Bhatnagar +3 more
semanticscholar +1 more source

